Fenoldopam mesylate (PM), a selective post-junctional dopaminergic (DA,) vasodilator, causes lesions of large caliber splanchnic arteries in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds of the rat, or in dogs or monkeys. Dopamine, like FM, causes hemorrhagic lesions of large caliber splanchnic arteries in the rat, as well as fibrinoid necrosis of small caliber arteries (< 100 Jlm) of the splanchnic, cerebral, coronary and renal vascular beds. Dopamine is an alpha-and beta-adrenoceptor and a dopaminergic receptor agonist. Because these arterial lesions are thought to result from the pharmacologic activity of these 2 compounds; we sought to ascertain the presence of DA, receptors in mesenteric arteries of the rat and to determine the role of these or other vascular receptor subtypes in lesion induction. We also studied the process of repair after arterial injury caused by FM or dopamine. The presence of DA 1 receptors was confirmed in isolated perfused mesenteric arteries by standard pharmacologic techniques; stimulation by PM resulted in vasodilation which was inhibited by the DA) receptor antagonist SK&F 83566-C. Likewise, SK&F 83566-C prevented the induction of hemorrhagic lesions of large caliber arteries in rats upon infusion of PM or dopamine. In rats co-exposed to the alpha-adrenoreceptor antagonist phenoxybenzamine (PBZ) and either FM or dopamine, the incidence and severity of hemorrhagic lesions oflarge caliber arteries were increased, but PBZ prevented the formation of dopamine-induced fibrinoid lesions in arteries ofsmall caliber. Rats exposed concurrently to dopamine, phenoxybenzamine, and SK&F 83566-C were free of all arterial lesions. Thus, the induction of splanchnic arterial lesions in the rat by dopamine and PM is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic DA 1 receptors. Fibrinoid lesions of small arteries (alphaadrenoceptor-mediated) were repaired, as observed morphologically by 14 d after exposure to dopamine. Hemorrhagic lesions of large caliber arteries (DA) receptor-mediated) had undergone significant repair by 28 d after exposure to PM but these arteries possessed a thicker media surrounded by adventitial fibrosis. Thus, morphologically distinct receptor-mediated splanchnic arterial lesions induced by dopaminergic and alpha-adrenoceptor agonists follow a markedly different course of repair. Arterial lesions induced by FM or dopamine by activation ofpost-junctional dopaminergic DA, receptors may represent a model of polyarteritis nodosa.
INTRODUCTION
In this paper, we will present our current understanding ofthe pathogenesis ofarterial lesions caused in the rat by fenoldopam mesylate (FM), a selective post-junctional dopaminergic DA l agonist (10, 21-23, 26, 29, 32) , and dopamine, an alpha-adrenergic, beta-adrenergic, and dopaminergic agonist (1, 9, 17, 25, 31) . FM-induced arterial lesions originally reported by Morgan and Yuhas (19, 35) , were only observed in the rat, and only after continuous intravenous infusion for 24 hr at doses ranging from 1 to 100~g/kg/min. Rats infused at 0.1~g/kg/min did not develop arterial lesions. Oral and continuous intravenous infusion toxicity studies of FM in the dog and monkey, and oral and intravenous (injection) studies in the rat did not yield arterial lesions (Morgan, unpublished observations) . FM-induced arterial lesions are characterized by medial necrosis 203 TOXICOLOGIC PATHOLOGY and hemorrhage and are restricted to arteries of larger caliber (10D-800 J,Lm) in the splanchnic and renal vascular beds. Dopamine, like norepinephrine, angiotensin, and other pressor agents (3, 8, 11, 13, 15, 16, 30) causes arterial lesions ofsmall caliber (< 100 J,Lm), distal arteries in the mesenteric arcade, as well as the renal and coronary arteries of the rat and the dog (Morgan and Kerns, unpublished observations). These lesions are characterized by medial fibrinoid necrosis and endothelial necrosis but with little accompanying medial hemorrhage. In addition, dopamine also causes hemorrhagic lesions of the splanchnic vasculature in the rat that are morphologically identical to those induced by FM. Such lesions are not induced by dopamine in the dog.
In this presentation, we will review the morphology ofthe lesions induced by FM and dopamine in the rat, and will describe the results of experiments with both compounds that elucidate the role of the alpha-adrenoceptor and dopaminergic DA 1 receptor in the pathogenesis of the arterial lesions. We will present evidence that supports the conclusion that dopaminergic DA 1 receptors exist in the mesenteric vasculature of the rat and that, when stimulated, they induce vasodilation and not vasoconstriction. We will postulate regarding possible mechanisms by which dopaminergic DA. and alpha-adrenoceptors may elicit arterial lesions in the rat, and comment on the remarkable similarities between the sequelae of DA 1 receptor-mediated arterial injury and polyarteritis nodosa, a spontaneous arterial disease of the rat. Evidence for this will be drawn from observations on the reversibility and repair of arterial lesions induced by FM and dopamine. Finally, we will address the morphologic similarities between phosphodiesterase (PDE) IIIinduced lesions of the coronary and mesenteric arteries in dogs and rats, respectively, andFM-induced lesions in the mesenteric vasculature of the rat.
METHODS AND RESULTS

In Vitro Characterization ofSplanchnic DA 1 Receptors
The purpose of these experiments was to characterize the receptor subtypes mediating vasoconstriction or vasodilation in the rat mesenteric vasculature. This was accomplished by evaluating the effects ofpharmacological receptor agonists and antagonists on perfusion pressure in an isolated segment of small intestine. This model permitted an assessment of vasoconstrictor and vasodilator responses ofmesenteric arteries in the absence ofsympathetic innervation in the intact animal.
Male Sprague-Dawley CD@ rats (Charles River Breeding Laboratories Inc., Wilmington, MA), weighing 200-300 g, were sacrificed humanely. The abdominal cavity was opened and a 15-20 ernlength ofdistal jejunum and ileum was isolated. The major arteries and veins supplying this length of intestine were ligated. The isolated intestine was transected at the ileocecal junction and distal jejunum and removed, with intact mesentery, from the abdominal cavity. The contents of the ileum were removed by flushingwith Krebs buffer.A 15-cm length ofPE240 Intramedic polyethylene tubing, which had been cut in half longitudinally except for 2 em at I end, was passed through the lumen of the intestine. The intact end of the tubing was placed in the distal jejunum and tied securely to facilitate perfusion of the intestine. The anterior mesenteric artery was cannulated with a 22-gaugeneedle attached to PESO Intramedic tubing. The mesenteric vein was incised and allowed to drain freely.
The entire specimen was placed in a water-jacketed Buchner funnel and bathed in Krebs buffer at 37°C.The arterial catheter was connected to a Buchler peristaltic pump which was set to deliver Krebs buffer at a constant flow rate of 0.9 ml/min. The intestinal lumen was perfused at a flow rate of 1.8 ml/min with Krebs buffer. The bufferswere kept at constant temperature (37°C) and aerated with 95% 0/5% CO 2;Arterial perfusion pressure was recorded with a Sanborne pressure transducer and recorder. After a 2Q-40-min equilibration period, during which the buffer in the water bath was changed 2-3 times, drugs were introduced into the perfusing solution via the arterial catheter.
Krebs buffer contained the following (rna): NaCl (118), KCl (4.7), CaCl 2 (2.5), MgCl 2 (1.2), NaHC0 3 (25), NaHP0 4 (1.0), ascorbate (0.02), and glucose (11.1). A sustained increase in perfusion pressure was achieved by infusion of methoxamine HCI (Burroughs-Welcome, NC).
In pilot studies, we determined that this preparation could be maintained only for a maximum of 2 hr, after which significant changes were seen in the intestinal villous epithelium and the endothelial lining of the mesenteric arteries. As a result, all in vitro studies were limited to 1 hr of perfusion.
To study inhibition of the response to vasoconstriction induced by methoxamine, the concentration of the agonist was adjusted to yield approximately 70% of the maximal response (EC 70 ) . Apparent K, values were calculated from the standard equation: antagonist concentration/dose ratio -1, where the dose ratio is the ECso(antagonist)/ ECso(agonist).
Methoxamine induced a concentration-dependent increase in arterial perfusion pressure. The in- crease in perfusion pressure could be blocked by the post-junctional alpha-adrenoceptor.antagonist, prazosin, with an apparent K, value of 6.3 x to-IO M, indicating that the increase in perfusion pressure with methoxamine is mediated through alpha-adrenoceptor stimulation (Fig. 1 ). In separate experiments, concentration response curves to FM were developed at concentrations ranging from 10-8 M to 10- 4 M. An increase in perfusion pressure was not observed over this concentration range indicating that FM does not induce vasoconstriction in the mesenteric arterial bed of the rat.
In further experiments, methoxamine, 3 x 10-s M, was used to induce a sustained elevation in arterial perfusion pressure. Thereafter, concentrationresponse curves were developed for the reduction of perfusion pressure by addition of FM to the perfusate. This resulted in a concentration-related reduction in perfusion pressure evoked by methoxamine, yielding an IC so for FM of 1.6 x 10-6 M (Fig.  2 ). To ensure that the relaxation of the methoxamine-induced contraction by FM was not due to alpha-adrenoceptor blockade, the experiment was repeated in the presence of l O:? M SK&F 83566-C, a selective dopaminergic DA I antagonist (2) .'When the preparation was pre-incubated for 15 min with SK&F 83566-C prior to the addition of 3 x 10-s M methoxamine (EC 70 ) , FM again induced relaxation but, in this experiment, much higher concentrations (IC so = 1.8 x 10-s M) were required (Fig. 2) . The apparent K, for SK&F 83566-C against FM was calculated to be 1.02 x to-8 M.
Thus, in these experiments, the relaxation of methoxamine-induced vasoconstriction produced by FM and attenuation of this response by SK&F 83566-C demonstrates that the rat mesenteric vasculature contains dopaminergic DA I receptors.
Intravenous Infusion Experiments with Fenoldopam Mesylate and Dopamine -
Male Charles River CD® rats (250-400 g) were exposed either to fenoldopam mesylate (FM) or dopamine (Calbiochem, San Diego, CA) or vehicle (0.9% NaCI or 8% propylene glycol diluted with saline) by continuous intravenous infusion (5~l/ min) for 24 hr. The rats were restrained in plasticribbed cages and had access to food and water during the infusion. Dopamine (50~glkglmin) or FM (lor 50 ug/kg/min) were either infused alone or were coadministered with a selective receptor antagonist. With the exception of phenoxybenzamine (PBZ), which was given subcutaneously 5 hr prior to FM or dopamine infusion, all other agonists and antagonists were infused via separately catheterized tail veins. Antagonists were infused 15 min prior to and 15 min after exposure to dopamine or FM. The following receptor antagonists were evaluated for the ability to attenuate or prevent the vascular lesions caused by FM or dopamine: phenoxybenzamine (10 mg/kg; alphaI and alpha, antagonist), propranolol (20~glkglmin; beta. and beta, antagonist), LY53857 (10~g/kg/min; serotonin [5HT 2l antagonist) ( (2, 20) . Each antagonist was also eval-TOXICOLOGIC PATHOLOGY uated alone for any pathological effects on the vascular system.
To facilitate the rapid and thorough macroscopic evaluation of the splanchnic vasculature, each rat was given an intravenous injection of Monastral Blue Bifil (Sigma Chemical Co., St. Louis, MO), I ml/kg of a 3% NaCl suspension, and sacrificed approximately I hr later by CO 2 inhalation (14). The rats were exsanguinated and the splanchnic vasculature was examined with a Wild Photomacroscope. The tissues were fixed in buffered formalin, processed routinely, and stained with hematoxylin and eosin (H&E) for microscopic evaluation. Macroscopically, normal arteries were evaluated microscopically to ensure that lesions were not present. Sections of stomach, ileum, cecum, pancreas, and mesentery were evaluated.
To examine arterial lesions ultrastructurally, tissues of rats infused with 50 JLg/kg/min of FM or 20 JLg/kg/min of dopamine, or saline for 1, 4 or 24 hr, were fixed by perfusion and processed routinely for examination by transmission and scanning electron microscopy.
Fenoldopam Mesylate. When infused for 24 hr, PM, at dosages of I or 50 ug/kg/min, induced arteriallesions of large caliber arteries (100-800 JLm) in the splanchnic vasculature, and ovarian and renal arteries, with dose-related frequency and severity. Lesions were not found in any other vascular bed. Macroscopically', lesions were characterized by focal, annular, or confluent medial hemorrhage (Fig.  3) . Microscopically, lesions consisted principally of medial necrosis and hemorrhage and a mild periarterial inflammatory response after 24 hr of infusion ( Fig. 4) .
' Ultrastructurally, the endothelium was intact after 24 hr of infusion but there was a significant loss of medial smooth muscle cells. The voids created by the loss of smooth muscle cells were filled with red blood cells and occasionally platelets (Figs. 5, 6).
In summary, we have demonstrated that in a doserelated fashion, FM induced medial smooth muscle cell necrosis and hemorrhage of large caliber splanchnic arteries. Smooth muscle cells, but not endothelial cells, appeared to be primarily involved in the pathogenesis of this lesion. arteries of the splanchnic vasculature after continuous intravenous infusion for 24 hr. Macroscopically, lesions of small caliber arteries were relatively non-hemorrhagic and were located in the most distal branches of the mesenteric arterial tree (Fig. 7) . Microscopically, lesions were characterized by medial smooth muscle cell necrosis with fibrin insudation ( Fig. 8 ). After 24 hr of infusion, there was a mild mononuclear, periarterial, inflammatory response. In contrast to the hemorrhagic lesions of large caliber arteries, these lesions frequently stained positive for fibrin.
Ultrastructurally, lesions of small caliber arteries appeared initially to involve the endothelium (Fig.  9 ). Endothelial necrosis preceded smooth muscle cell necrosis and fibrin accumulation within the media. After 24 hr, there was evidence of extensive endothelial necrosis and medial fibrinoid necrosis and adherence of platelets to the denuded internal elastic lamina (Fig. 10 ).
Agonist/Antagonist Studies. As noted above, the arterial lesions induced by PM and dopamine are morphologically and anatomically distinct. The lesions affect vessels which are known to respond to stimulation both by vasoconstrictor and vasodilator agonists i.e., alpha-adrenoceptor as well as dopaminergic agonists. These observations led to the hypothesis that both kinds of arterial lesions could be mediated through the pharmacological activity of FM and dopamine. To test this hypothesis further, we investigated the effects of selective receptor antagonists in preventing or attenuating the arterial lesions.
Of the rats co-exposed to FM and a variety of receptor antagonists, only SK&F 83566-C, a selective, dopaminergic DA J antagonist prevented the development of arterial lesions. Prevention and attenuation of lesions was dose-dependent with respect both to their incidence and severity. Antagonism of pre-and post-junctional alpha-adrenergic receptors by PBZ increased both the frequency and severity of FM-induced lesions, particularly at the lower dosage of 1.0 JLglkglmin. Antagonism ofbetaadrenergic receptors (propranolol), pre-junctional, dopaminergic DA 2 receptors «s)-sulpiride), and serotonergic receptors (LY53857) did not alter the incidence, frequency or severity of arterial lesions caused by FM. None of these antagonists produced lesions when administered alone. SK&F 83566-C, when infused alone, produced a single, microscopic hemorrhagic lesion at a dose of 10~g/kg/min, which suggests that it may possess some agonist activity at the DA 1 receptor.
In co-exposure studies with dopamine and PBZ, arterial lesions were restricted to larger caliber arteries and occurred with increased incidence and severity in both the mesenteric arcade, cecal arteries, and pancreatic artery (Fig. 11) . Alpha-adrenergic receptor antagonism eliminated the medial fibrinoid lesions of small caliber arteries. Thus, although PBZ pretreatment prevented the development of the medial fibrinoid lesions in the distal branches of the mesenteric arcade in all rats, hemorrhagic lesions of larger arteries increased in severity. Dopamine administered alone did not induce medial necrosis and hemorrhage of the rat pancreatic artery but PBZ pretreatment resulted in characteristic lesions ofthe type induced by FM at this site. None of the rats exposed to dopamine, and a combination of PBZ and SK&F 83566-C, developed arterial lesions of any kind.
Reversibility and Repair Studies
Clinicallyhealthy, male rats; 5/drug-treatedgroup, were infused continuously via a tail vein for 24 hr either with FM (50~g/kg/min) or with dopamine hydrochloride (20~g/kg/min). Tissue sections from the stomach, pancreas, mesentery, and colon were examined by light microscopy to study the reversibility and repair of splanchnic arterial lesions.
Three days following termination of a 24-hr infusion with dopamine, the small caliber resistance arteries of the splanchnic bed were characterized by medial fibrinoid necrosis and, in most arteries, a mild, mononuclear, periarterial inflammatory response. On day 7 post-infusion, there was minimal medial hypertrophy and hyperplasia. On day 28 postinfusion, there was no evidence of arterial disease and the morphological appearance of peripheral arteries was restored to normal.
Large caliber splanchnic arteries of rats infused with FM for 24 hr exhibited a response to injury that was considerably different from that associated with the alpha-adrenoceptor, pressor-mediated effects of dopamine. On day 3 post-infusion, lesions of large caliber arteries were characterized by extensive medial necrosis and hemorrhage and a marked periarterial inflammatory response. Inflammation consisted of an infiltration of macrophages and neutrophils, and a marked proliferation of fibroblasts in the periadventitial tissues ( Fig. 12 ). By day 7 post-infusion, most affected arteries were characterized by extensive hypertrophy and hyperplasia of medial smooth muscle cells. By day 14 post-infusion, the inflammatory response had subsided. On day 28 post-infusion, the affected arteries were characterized by further hypertrophy and hyperplasia of medial smooth muscle cells, and minimal to moderate adventitial fibroplasia. At this stage, the media ofaffectedarteries was considerably thicker when compared to the corresponding control arteries (Fig. 13 ). Although significant repair was evident in the FM-treated animals, complete resolution did not occur by day 28 post-infusion. DISCUSSION These experiments demonstrate that the 2 dopaminergic agonists, FM and dopamine, induced medial necrosis and hemorrhage of large caliber splanchnic arteries in the rat when administered by continuous intravenous infusion. The lesions produced by FM and dopamine appear to be mediated by the activation of the post-junctional DA 1 receptor as evidenced by blockade oflesion development with the DA( antagonist, SK&F 83566-C. Therefore, these compounds appear to produce this lesion by a specific pharmacologic action and not by a direct cytotoxic action. This hypothesis is further substantiated by the demonstration of the presence of'Da, receptors in the rat's mesenteric vasculature.
These observations were made in isolated perfused arteries of the mesenteric bed. The arterial lesion produced by FM and dopamine was not the result of alpha-adrenoceptor-mediated vasoconstriction because PBZ pretreatment provided no protection.
Dopamine also induced a pressor-mediated lesion of small caliber resistance vessels in several vascular beds. This lesion was characterized by medial fibrinoid necrosis and minimal hemorrhage. These lesions could be inhibited by an alpha-adrenoceptor antagonist but not by a selective DA( receptor antagonist. This type of lesion, induced by dopamine, was distinctly different in morphology and anatomic distribution when compared with FM-induced arterial lesions. These different arterial lesions may parallel the distribution or concentration ofreceptor subtypes in the rat splanchnic vasculature. It is also evident that some interaction between alpha-adrenoceptors and OAt receptors may determine the ultimate expression and development of medial necrosis and hemorrhage in large caliber arteries, since alpha-adrenoceptor blockade increased the severity of such lesions produced by FM and dopamine, and alpha adrenoceptor blockade also induced lesions in pancreatic arteries which did not develop with dopamine alone. It is possible that"maintenance of vascular tone is important in moderating or preventing full expression of medial injury caused by activation of DA( receptors.
The results of ultrastructural studies suggest that differences exist between the pathogenesis of fibrinoid and hemorrhagic lesions within the arterial wall.
Medial smooth muscle cells appear to be the primary site of injury in large caliber' arteries affected by the DA. receptor-mediated hemorrhagic lesions. The endothelium is the initial site of injury in small caliber vessels affected by fibrinoid lesions resulting from the vasoconstrictor effects of alpha-adrenoceptor stimulation. Endothelial damage induced by the vasoconstrictor effect of dopamine early in the course of lesion development may account for the deposition offibrin in the media. On the other hand, red blood cells and platelets entered the media of large caliber arteries affected by DA. receptor-mediated damage by a process resembling diapedesis, since the endothelium and internal elastic lamina remained intact, even in arteries with severe and advanced medial necrosis. Fibrin may be excluded from this kind of lesion because spaces within the media, resulting from lysis of smooth muscle cells, are apparently filled instantly with red blood cells.
Studies of arterial repair following injury with either dopamine or FM suggest that arterial lesions evoked by stimulation of alpha-adrenoceptors or DA 1 receptors followed a different course of regeneration and repair. Dopamine-induced lesions appear to be totally reversible after 14 d of recovery. Arterial repair following FM-induced injury, although substantial, is incomplete after 28 d of recovery. Moreover, at this stage of recovery, the lesions resembled the naturally occurring arteritis of the splanchnic vasculature in rats, commonly known as polyarteritis nodosa. This disease is recognized in mature male SHR rats with the incidence ranging up to 100% (28, 33) , and in Sprague-Dawley rats where the incidence is reported to be 1-3% (34) . In a recently completed 2-yr carcinogenicity study of FM, a dose-related increase in the incidence ofpolyarteritis nodosa was observed in the splanchnic vasculature of Sprague-Dawley CD® rats. The incidence in the high-dose group receiving up to 25 mg/ kg!d orally, by gavage, exceeded 50% in male rats (Morgan, unpublished observations).
Since this symposium is focused principally on spontaneous and drug-induced arterial lesions of dogs, including among the latter those induced by the phosphodiesterase (PDE) III inhibitors, some comment in this area seems appropriate. It has been FIG. 13.-Day 28 post-infusion in a rat exposed to PM (50~g/kg/min) for 24 hr. Although the media has been repaired, it is markedly thickened. The adventitia isvascularized and contains hemosiderim laden macrophages, H&E. x50.
reported at this meeting and in the literature that the PDE III inhibitors not only cause coronary arteriallesions in dogs, but also cause arterial 'lesions (polyarteritis nodosa) in rats that are restricted to the splanchnic vasculature (6, 12, 18) . It is also reported at this symposium that SK&F 95654, a selective PDE III inhibitor, causes iesions of the coronary arteries when infused intravenously in dogs. We have recently shown (Kerns and Joseph, unpublished observations) that SK&F 95654 causes lesions oflarge caliber splanchnic arteries in the rat that are morphologically identical to lesions caused by FM. FM elevates intracellular cAMP by its interaction with the DA 1 receptor (5, 7, 24, 27) , whereas the PDE III inhibitors increase cAMP by inhibiting intracellular phosphodiesterase. Since both pharmacologic'approaches elevate the intracellular concentration of cAMP, albeit by different mechanisms, it is reasonable to speculate, therefore, that this may represent a common pathway in the pathogenesis of arterial lesions caused by dopaminergic (DA,) agonists and PDE III irihibitors in the rat. It is also reasonable to speculate,' therefore, that the PDE III-mediated coronary arterial lesions of the dog are mediated through the pharmacological ac- These experiments have demonstrated that the rat, in contrast to other laboratory animal species, is uniquely sensitive to the development ofa novel, pharmacologically-mediated lesion of large caliber splanchnic arteries when exposed to compounds which increase intracellular cAMP. This includes the post-junctional DA. receptor agonists, FM and dopamine, and PDE III inhibitors like SK&F 95654.
The absence ofDA l receptor-mediated lesions in the dog and monkey administered FM or dopamine, and the safe clinical use of both compounds in human patients to date, provides considerable assurance that the intravenous administration of FM to human patients should not result in adverse effects on the vasculature.
